ctrl K

Bright Minds Biosciences ... (DRUG)

32.68

-0.03 (-0.09%)

At close: Apr 28, 2025, 3:59 PM

32.71

0.09%

After-hours: Apr 28, 2025, 07:52 PM EDT

Bright Minds Biosciences Income Statement

Financials in CAD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-2.62M	-7.2M	-14.73M	-8.62M	-474.93K	-236.15K
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-2.8M	-7.37M	-14.96M	-8.65M	-480.38K	-236.15K
Net Income	-2.8M	-7.37M	-14.96M	-8.65M	-480.38K	-236.15K
Selling & General & Admin	1.44M	2.2M	2.55M	2.31M	120.07K	110.12K
Research & Development	1.18M	5M	12.18M	6.31M	354.85K	126.03K
Other Expenses	n/a	n/a	-0.00	0.00	0.00	0.00
Operating Expenses	2.62M	7.2M	14.73M	8.62M	474.93K	236.15K
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	41.6K	119.42K	551.86K	852.15K	9.62K	n/a
Cost & Expenses	2.62M	7.2M	14.73M	8.62M	474.93K	236.15K
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	4.31M	3.72M	2.47M	1.79M	1.28M	1.28M
Shares Outstanding (Diluted)	4.31M	3.72M	2.47M	1.79M	1.28M	1.28M
EPS (Basic)	-0.65	-1.98	-6.15	-4.74	-0.38	-0.06
EPS (Diluted)	-0.65	-1.98	-6.15	-4.74	-0.38	-0.06
EBITDA	n/a	-7.28M	-14.96M	n/a	n/a	n/a
EBIT	-2.62M	-7.35M	-14.73M	-8.65M	-474.93K	-236.15K
Depreciation & Amortization	2.62M	72.45K	6.04K	8.62M	474.93K	236.15K